Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000499834 | SCV000590920 | pathogenic | Hereditary cancer | 2017-06-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535628 | SCV004111391 | likely pathogenic | PTEN-related disorder | 2022-12-22 | criteria provided, single submitter | clinical testing | The PTEN c.196A>T variant is predicted to result in premature protein termination (p.Lys66*). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in PTEN are expected to be pathogenic and neighboring premature-termination variants have been reported in association with disease (see for example, p.Tyr65*, Tan. 2011 et al. PubMed ID: 21194675). Taken together, the c.196A>T (p.Lys66*) variant is interpreted as likely pathogenic. |